Blood circulation promotion

Blood circulation promotion describes a nonspecific property of drugs or interventions that increase blood flow or improve hemorheology, commonly used in the context of traditional medicines—such as *Salvia miltiorrhiza* extracts—to treat diseases related to blood stasis or vascular disorders. While certain molecular mechanisms (e.g., vasodilation, platelet inhibition, modulation of endothelial function) and targets (such as AKT1, IL-6, EGFR, NO/ET-1 pathways) are implicated in the process[3][2][1], "blood circulation promotion" itself is not a singular, specific molecular target but a functional endpoint involving multiple overlapping biological systems. In summary, "blood circulation promotion" is a therapeutic concept, not a distinct molecular entity or receptor, and should not be treated as a canonical pharmacological target[3][2].

Other names

Promotion of blood circulationImprove blood flowBlood flow enhancement